Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha

Meral Calgüneri; Ahmet Mesut Onat; M Akif Oztürk; Levent Ozçakar; Kemal Ureten; Ali Akdogan; Ihsan Ertenli; Sedat Kiraz

doi:10.1007/s10067-004-0944-1

Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha

Clin Rheumatol. 2005 Feb;24(1):64-6. doi: 10.1007/s10067-004-0944-1. Epub 2004 Oct 26.

Authors

Meral Calgüneri¹, Ahmet Mesut Onat, M Akif Oztürk, Levent Ozçakar, Kemal Ureten, Ali Akdogan, Ihsan Ertenli, Sedat Kiraz

Affiliation

¹ Department of Rheumatology, Hacettepe University Medical School, Ilkadim mah Namdar sok 17/16 Dikmen, Ankara, Turkey.

PMID: 15517447
DOI: 10.1007/s10067-004-0944-1

Abstract

We report here on a 24-year-old patient with Behcet's disease who had been diagnosed with acute transverse myelitis. He was successfully treated with a combination regimen of a steroids, cyclophosphamide, and interferon-alpha. The treatment strategy with specific emphasis on interferon-alpha is discussed in the light of the pertinent literature.

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Behcet Syndrome / complications
Behcet Syndrome / diagnosis
Behcet Syndrome / drug therapy*
Drug Administration Routes
Drug Therapy, Combination
Follow-Up Studies
Glucocorticoids / administration & dosage
Gout Suppressants / administration & dosage
Humans
Immunologic Factors / therapeutic use*
Immunosuppressive Agents / administration & dosage
Interferon-alpha / therapeutic use*
Magnetic Resonance Imaging
Male
Myelitis, Transverse / complications
Myelitis, Transverse / diagnosis
Myelitis, Transverse / drug therapy*
Spinal Cord / pathology
Treatment Outcome

Substances

Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Glucocorticoids
Gout Suppressants
Immunologic Factors
Immunosuppressive Agents
Interferon-alpha